PIROXICAM

Post-LOE

piroxicam

ANDAORALCAPSULE
Approved
Sep 2016
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
3

Clinical Trials (3)

NCT05104931Phase 1Completed

PK Evaluation of a Nanoformed Oral IR Piroxicam Tablet in Healthy Subjects

Started Dec 2020
NCT01320709Phase 2Completed

Effect of Piroxicam on Ovulation

Started Mar 2011
72 enrolled
Contraception, Postcoital
NCT00649415Phase 4Completed

A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg Twice Daily, As Needed In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea

Started Jan 2003
154 enrolled
Dysmenorrhea